Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Applovin
APP
|
$1.3B |
| 2 |
e.l.f. Beauty
ELF
|
$339M |
| 3 |
DraftKings
DKNG
|
$247M |
| 4 |
Datadog
DDOG
|
$212M |
| 5 |
Pinduoduo
PDD
|
$188M |
Top Sells
| 1 |
Tesla
TSLA
|
$2.11B |
| 2 |
NVIDIA
NVDA
|
$1.42B |
| 3 |
Spotify
SPOT
|
$1.08B |
| 4 |
Mercado Libre
MELI
|
$668M |
| 5 |
Moody's
MCO
|
$588M |
Sector Composition
| 1 | Consumer Discretionary | 30.95% |
| 2 | Technology | 29.07% |
| 3 | Communication Services | 17.02% |
| 4 | Healthcare | 9.5% |
| 5 | Financials | 5.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Health Catalyst
HCAT
$239M
| – | – |
-121,855
| Closed | -$992K |
|
277
Intel
INTC
$106B
| – | – |
-700
| Closed | -$16.4K |
|
278
Ionis Pharmaceuticals
IONS
$9.16B
| – | – |
-39,581
| Closed | -$1.59M |
|
279
Lyell Immunopharma
LYEL
$219M
| – | – |
-141,949
| Closed | -$196K |
|
280
Mettler-Toledo International
MTD
$26.3B
| – | – |
-97,005
| Closed | -$145M |
|
281
ResMed
RMD
$39.7B
| – | – |
-15,500
| Closed | -$3.78M |
|
282
10x Genomics
TXG
$1.66B
| – | – |
-40,378
| Closed | -$912K |
|
283
Vir Biotechnology
VIR
$695M
| – | – |
-2,383,029
| Closed | -$17.8M |
|
|
ZUO
284
DELISTED
Zuora, Inc.
ZUO
| – | – |
-2,454,747
| Closed | -$21.2M |
|
|
EXAI
285
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| – | – |
-3,848,276
| Closed | -$18.8M |
|